Study on the Effects of NMRA-335140 for Adults with Major Depressive Disorder
Poland- Participants:18–64 years
- Substances:1-[6-Ethyl-8-Fluoro-4-Methyl-3-(3-Methyl-1,2,4-Oxadiazol-5-Yl)Quinolin-2-Yl]-N-(Oxan-4-Yl)Piperidin-4-Amine
Rare diseases
Investigational molecules
Locations
Poland
PolandStudy of Tofacitinib for Children with Moderate to Severe Ulcerative Colitis
Poland
PolandStudy Comparing Talquetamab, Daratumumab, and Pomalidomide with Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma
PolandStudy on the Effects of AZD5462 for Patients with Stable Chronic Heart Failure
PolandStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
PolandStudy Comparing Pirtobrutinib with Idelalisib and Rituximab or Bendamustine and Rituximab for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
PolandStudy on the Effectiveness and Safety of EDP-938 for Adults with High-Risk Respiratory Syncytial Virus (RSV) Infection
PolandStudy Comparing Belantamab Mafodotin with Pomalidomide and Dexamethasone to Bortezomib with Pomalidomide and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma
PolandStudy on Ofatumumab for Patients with Relapsing Multiple Sclerosis Transitioning from Fumarate-Based Therapies or Fingolimod
PolandStudy on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.